Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
418.13
+3.52 (0.85%)
At close: Sep 28, 2026, 4:00 PM EDT
418.10
-0.03 (-0.01%)
Pre-market: Sep 29, 2026, 8:02 AM EDT
Amgen Stock Forecast
Stock Price Forecast
According to 34 analysts polled by S&P Global, Amgen stock has a consensus rating of "Hold" and an average price target of $388.43. The average 1-year stock price forecast is 7.10% lower than the current stock price, while the lowest is $225 (-46.19%) and the highest is $457 (+9.30%).
Price Target: $388.43 (-7.10%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Amgen stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 6 | 5 | 10 | 8 |
| Buy | 2 | 2 | 2 | 4 | 4 | 4 |
| Hold | 3 | 3 | 3 | 2 | 16 | 18 |
| Sell | 0 | 0 | 0 | 0 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 2 | 2 |
| Total | 12 | 12 | 11 | 11 | 34 | 34 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Buy Maintains $450 → $500 | Buy | Maintains | $450 → $500 | +19.58% | Sep 28, 2026 |
| Raymond James | Raymond James | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Sep 25, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Sep 24, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Hold Maintains $367 → $410 | Hold | Maintains | $367 → $410 | -1.94% | Sep 23, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $450 | Buy | Maintains | $450 | +7.62% | Sep 23, 2026 |
Financial Forecast
Revenue This Year
38.94B
from 36.75B
Increased by 5.95%
Revenue Next Year
40.31B
from 38.94B
Increased by 3.52%
EPS This Year
23.06
from 21.84
Increased by 5.57%
EPS Next Year
24.45
from 23.06
Increased by 6.04%
EPS and Forward PE are based on non-GAAP adjusted numbers.